Cargando…

Natural product ligands of FKBP12: Immunosuppressive antifungal agents FK506, rapamycin, and beyond

Detalles Bibliográficos
Autores principales:	Rivera, Angela, Heitman, Joseph
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2023
Materias:	Pearls
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9836287/ https://www.ncbi.nlm.nih.gov/pubmed/36634035 http://dx.doi.org/10.1371/journal.ppat.1011056

Ejemplares similares

Harnessing calcineurin-FK506-FKBP12 crystal structures from invasive fungal pathogens to develop antifungal agents
por: Juvvadi, Praveen R., et al.
Publicado: (2019)

Tomato FK506 Binding Protein 12KD (FKBP12) Mediates the Interaction between Rapamycin and Target of Rapamycin (TOR)
por: Xiong, Fangjie, et al.
Publicado: (2016)

Development of Non-Immunosuppressive FK506 Derivatives as Antifungal and Neurotrophic Agents
por: Jung, Jin A, et al.
Publicado: (2020)

The immunosuppressive and toxic effects of FK-506 are mechanistically related: pharmacology of a novel antagonist of FK-506 and rapamycin
Publicado: (1992)

Interactions of FK506 and Rapamycin With FK506 Binding Protein 12 in Opportunistic Human Fungal Pathogens
por: Vellanki, Sandeep, et al.
Publicado: (2020)

Analysing the visible conformational substates of the FK506-binding protein FKBP12
por: Mustafi, Sourajit M., et al.
Publicado: (2013)

An improved reversibly dimerizing mutant of the FK506-binding protein FKBP
por: Barrero, Juan J., et al.
Publicado: (2016)

Crystal structure and conformational flexibility of the unligated FK506-binding protein FKBP12.6
por: Chen, Hui, et al.
Publicado: (2014)

Differential conformational dynamics in the closely homologous FK506-binding domains of FKBP51 and FKBP52
por: Mustafi, Sourajit M., et al.
Publicado: (2014)

Structural basis of conformational transitions in the active site and 80′s loop in the FK506-binding protein FKBP12
por: Mustafi, Sourajit M., et al.
Publicado: (2014)

Identification of Tropoelastin as a Ligand for the 65-kD FK506-binding Protein, FKBP65, in the Secretory Pathway
por: Davis, Elaine C., et al.
Publicado: (1998)

FKBP12-Dependent Inhibition of Calcineurin Mediates Immunosuppressive Antifungal Drug Action in Malassezia
por: Ianiri, Giuseppe, et al.
Publicado: (2017)

FK506 immunosuppression for submandibular salivary gland allotransplantation in rabbit
por: Almansoori, Akram Abdo, et al.
Publicado: (2020)

FK506-binding protein, FKBP12, promotes serine utilization and negatively regulates threonine deaminase in fission yeast
por: Sasaki, Mayuki, et al.
Publicado: (2022)

Analysis of FK506, timcodar (VX-853) and FKBP51 and FKBP52 chaperones in control of glucocorticoid receptor activity and phosphorylation
por: Hinds, Terry D, et al.
Publicado: (2014)

Posaconazole Exhibits In Vitro and In Vivo Synergistic Antifungal Activity with Caspofungin or FK506 against Candida albicans
por: Chen, Ying-Lien, et al.
Publicado: (2013)

The effects of over-expression of the FK506-binding protein FKBP12.6 on K(+) currents in adult rabbit ventricular myocytes
por: Kettlewell, S., et al.
Publicado: (2009)

FK506 binding protein 5 (FKBP5) gene polymorphisms and their relationship with pharmacological response in bipolar disorders
por: Arnone, Danilo
Publicado: (2020)

FK506-binding protein 2 (FKBP13) inhibit Bax-induced apoptosis in Saccharomyces cerevisiae (yeast)
por: Akintade, Damilare D., et al.
Publicado: (2021)

Erratum for Ianiri et al., “FKBP12-Dependent Inhibition of Calcineurin Mediates Immunosuppressive Antifungal Drug Action in Malassezia”
por: Ianiri, Giuseppe, et al.
Publicado: (2017)

Structural basis of nucleic acid recognition by FK506-binding protein 25 (FKBP25), a nuclear immunophilin
por: Prakash, Ajit, et al.
Publicado: (2016)

FK506-binding protein 10 (FKBP10) regulates lung fibroblast migration via collagen VI synthesis
por: Knüppel, Larissa, et al.
Publicado: (2018)

Association of job stress, FK506 binding protein 51 (FKBP5) gene polymorphisms and their interaction with sleep disturbance
por: Li, Peixin, et al.
Publicado: (2023)

Transient conformations in the unliganded FK506 binding domain of FKBP51 correspond to two distinct inhibitor-bound states
por: Anderson, Janet S., et al.
Publicado: (2023)

Maculopathy Associated with Tacrolimus (FK 506)
por: Koh, Taehyuk, et al.
Publicado: (2011)

IINFLUENCE OF THE IMMUNOSUPPRESSANT TACROLIMUS (FK-506) ON THE FLEXURAL STRENGTH OF FEMUR: A STUDY IN RATS
por: Pithon, Matheus Melo, et al.
Publicado: (2015)

Rapamycin-mediated mTORC2 inhibition is determined by the relative expression of FK506-binding proteins
por: Schreiber, Katherine H, et al.
Publicado: (2015)

Rapamycin inhibits AR signaling pathway in prostate cancer by interacting with the FK1 domain of FKBP51
por: Zhang, Jing, et al.
Publicado: (2020)

The FK506 binding protein 13 kDa (FKBP13) interacts with the C-chain of complement C1q
por: Neye, Holger, et al.
Publicado: (2004)

Association of SNPs in the FK-506 binding protein (FKBP5) gene among Han Chinese women with polycystic ovary syndrome
por: Ma, Xinyue, et al.
Publicado: (2022)

In vitro effect of a non-immunosuppressive FKBP ligand, FK1706, on SARS-CoV-2 replication in combination with antivirals
por: Fitzsimmons, William E., et al.
Publicado: (2022)

Effects of immunosuppressants, FK506 and cyclosporin A, on the osteogenic differentiation of rat mesenchymal stem cells
por: Byun, Yu-Kyung, et al.
Publicado: (2012)

FKBP51 and Cyp40 are Positive Regulators of Androgen-dependent Prostate Cancer Cell Growth and the Targets of FK506 and Cyclosporin A
por: Periyasamy, Sumudra, et al.
Publicado: (2009)

FK506 Induces Ligand-Independent Activation of the Bone Morphogenetic Protein Pathway and Osteogenesis
por: Sangadala, Sreedhara, et al.
Publicado: (2019)

Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice
por: Caduff, Nicole, et al.
Publicado: (2020)

Structure-Guided Synthesis of FK506 and FK520 Analogs with Increased Selectivity Exhibit In Vivo Therapeutic Efficacy against Cryptococcus
por: Hoy, Michael J., et al.
Publicado: (2022)

The Effect of FK 506 on the Reepithelialization of Superficial Skin Wound
por: Shin, Jeong Min, et al.
Publicado: (2017)

Correction: Immunosuppressive FK506 treatment leads to more frequent EBV-associated lymphoproliferative disease in humanized mice
por: Caduff, Nicole, et al.
Publicado: (2020)

Immunosuppressive effect of PLGA-FK506-NPs in treatment of acute cardiac rejection via topical subcutaneous injection
por: Deng, Cheng, et al.
Publicado: (2021)

Antifungal Drug Discovery: Something Old and Something New
por: Butts, Arielle, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_iqc3bk9r42ba5nksk7skmtmdks